During the past decade, Holy Cross Medical Group conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Holy Cross Medical Group" #1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator, "Pfizer" with 1 trials as a collaborator and "Thrombolysis In Myocardial Infarction (TIMI) Academic Research Organization" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Holy Cross Medical Group" are "Atrial Fibrillation" (1 trials), "Cardiovascular Disease" (1 trials), "Heart Failure" (1 trials), "High Cardiovascular Risk" (1 trials) and "Obesity" (1 trials). Many other conditions were trialed in "Holy Cross Medical Group" in a lesser frequency.

Most popular intervention types in "Holy Cross Medical Group" are "Device" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Biomarker-guided care NT-proBNP" (1 trials), "Lorcaserin hydrochloride" (1 trials), "Placebo" (1 trials) and "Usual Care" (1 trials). Other intervention names were less common.

The vast majority of trials in "Holy Cross Medical Group" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Holy Cross Medical Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Holy Cross Medical Group, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Holy Cross Medical Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".